Boston Scientific BSX

Boston Scientific Corp · NYSE · Surgical & Medical Instruments & Apparatus

$42.43-5.84%close on Oct. 28, 2026 · volume 69.4M · Yahoo Finance

Price, last 47 sessions

$42.50$45.00$47.50Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $49.86 · low $41.58 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Aug. 25, 2026Susan E. Morano
director
Bought2,040$49.22$100,408
Aug. 5, 2026David C. Habiger
director
Bought2,100$47.59$99,937
Aug. 4, 2026David C. Habiger
director
Bought140$48.59$6,802
Aug. 3, 2026David C. Habiger
director
Bought1,042$48.07$50,084
Aug. 3, 2026Michael F. Mahoney
Chairman, President & CEO, director
Bought186,240$48.33$9.00 million
July 31, 2026Edward J. Ludwig
director
Bought5,000$45.48$227,400

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 18 →
  • 8-KOct. 28, 2026, 6:34 a.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedBoston Scientific Q3 2026 adjusted EPS of $0.73 beats $0.72 consensus on $5.138 billion sales, but Q4 and full-year adjusted EPS guidance falls below consensus

  • 8-KOct. 7, 2026, 6:11 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Other events · Financial statements and exhibits

  • 8-KSept. 23, 2026, 6:01 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers

  • 8-KSept. 8, 2026, 6:15 a.m. ETView on SEC.gov

    Material cybersecurity incident

  • 4Sept. 3, 2026, 4:34 p.m. ETView on SEC.gov
  • 4Aug. 26, 2026, 6:46 p.m. ETView on SEC.gov
  • 8-KAug. 26, 2026, 6:06 a.m. ETView on SEC.gov

    Other events

  • 4Aug. 12, 2026, 4:08 p.m. ETView on SEC.gov